The Grayson Saves Foundation invites you to join us in funding what will change the way Pediatric Brain Tumors are treated in the near future.
For the last year, the Foundation has helped fund research for the development of GPC2 CAR T cells for high grade brain tumors. Especially the development of GD2 CAR for Diffuse Intrinsic Pontine Glioma (DIPG). DIPG is one of the highest causes of cancer related death in children with a near zero percent survival rate. At the current time, studies have yielded impressive tumor killing results in trails conducted on mice.
The research is being conducted by Dr. Jessica Foster MD at the Children’s Hospital of Philadelphia. Her findings will be presented at the 2019 Pediatric Society of Neuro-Oncology this May.
We, at The Grayson Saves Foundation, are proud to announce that the foundation has contributed over $40,000.00 towards this research. These funds have helped ensure that Dr. Foster can continue her research. Research that will indefinitely change the way Pediatric Brain Tumors are treated.
In this season of resolution and intention making, the Foundation has set a goal of raising $100,000.00 in 2019. These funds going entirely to support T Cell Immunotherapy for Pediatric Brain Tumors. We are asking for your help in achieving this advantageous goal. We are hoping you will join us in making a difference for the children currently in treatment and those children who have yet to be diagnosed.
Speak Your Mind